The instant application is a US non-provisional application based on U.S. provisional application No. 61/167,741, filed Apr. 8, 2009, the disclosure of which is hereby expressly incorporated by reference hereto in its entirety.
1. Field of the Invention
This invention relates generally to syringes, e.g., hypodermic syringes, such are utilized for injection of medicament into the body tissues of human and animal patients. More specifically, this invention relates to a hypodermic syringe having a plunger, piston and needle support structure or needle unit that permits retraction of the needle support and its needle into the plunger of the syringe to prevent the possibility of inadvertent needle pricks and which incorporates a frangible plunger seal that may be broken away to prevent subsequent use or re-use of the syringe.
This invention also relates to single-use syringes which automatically retracts the needle into the syringe when the plunger is substantially fully depressed which is more easily and/or less costly to produce.
This invention also relates to syringes which can be used only once, i.e., single-use syringes, and/or to syringes which utilize a built-in safety system which cannot be easily overridden by a user thereof.
2. Discussion of Background Information
In hospitals, nursing home facilities and the like, injection of medicament into the body tissues of patients is done on a daily basis. Typical hypodermic syringes are provided with a barrel having a needle that is fixed or removably attached at one end thereof. A plunger typically having an elastomeric piston is movable within the barrel to load the barrel with liquid medicament by suction as the plunger and piston are moved within the barrel in a direction away from the needle. After the needle has penetrated the body tissues of the patient, as the direction of movement of the plunger and piston are reversed and the piston is forced toward the needle, medicament contained within the barrel will be injected through the needle into the body tissues.
After hypodermic syringes have been used in this manner, those syringes that are disposable present a significant problem to users, e.g., hospital or nursing home staff, because the possibility of inadvertent needle pricks subject personnel to the possibility of cross-contamination by, among other things, virile or bacterial contaminants that might be present on the needle after its use. In an effort to avoid the possibility of inadvertent needle pricks special waste containers are often provided at hospital facilities into which the used disposable hypodermic syringes are placed. These containers and the syringes contained therein are then disposed of in a specifically organized manner to insure against the possibility of inadvertent infectious contamination of nursing personnel. Further, refuse handlers and other persons who might inadvertently come into contact with the used hypodermic syringes are also subject to the same hazards. Often times the needles themselves are bent over so as to minimize the possibility of inadvertent needle pricks and to preclude the possibility of subsequent use of disposable hypodermic syringes.
In certain situations, medicaments are injected into patients and not quickly thereafter discarded properly. Instead, the used syringe is placed in a temporary position. After the procedure has ended, the syringe can be manually recovered for disposal. However, between the time of use and the time of disposal, there is the possibility that inadvertent needle pricks will occur. Accordingly, it is desirable to provide a suitable way protecting personnel, e.g., nursing personnel, paramedics and other persons, from the hazards of inadvertent needle pricks as they go about their daily tasks.
It is therefore desirable to provide a syringe that includes a system for rendering the needle thereof to a protected, completely encapsulated condition such that it is less likely to cause, after use, an inadvertent needle prick during its handling or during its disposal. It is also desirable to provide a syringe having the capability of causing the automatic retraction of the needle to a position inside the plunger of the syringe and maintaining the needle in its retracted position so that the needle of the syringe is always enclosed after its use, thus precluding the possibility that the needle might cause an accidental needle prick as the syringe is subsequently handled. It is also desirable to provide a syringe of the disposable type that is provided with facility for rendering it completely inoperative such that it can not be subsequently used. Additionally, it is desirable to provide for a syringe which also has minimal dead-space so that it can be ideally used for injecting very expensive medicaments with minimal waste. Finally, it is desirable to provide for a syringe which also has a system for selectively locking the plunger in a substantially fully depressed position so that the syringe can have dual, multiple, and/or parallel safety systems, i.e., one system can include causing the needle unit to retract into the plunger and another system can include locking the plunger in a substantially fully depressed position.
According to one non-limiting aspect of the invention there is provided an injection device comprising a barrel, a hollow plunger having a portion structured and arranged to move within the barrel, a needle unit, and a safety system that one of automatically causes the needle unit to retract into the plunger when the plunger reaches a substantially fully depressed position and utilizes a frangible or breakable seal arranged within the plunger.
The injection device may be a single-use syringe. The barrel may comprise a cylindrically shaped internal space structured and arranged to receive therein a medicine. The barrel may further comprise a proximal opening within which the needle unit is at least one of press fit and in sealing engagement therewith. The plunger may comprise a piston arranged at a proximal area of the plunger and an actuating end arranged in front of the piston. The plunger may further comprise at least one of the piston being an elastomer or rubber piston, a hollow space sized and configured to receive therein the needle unit in its entirety, and a locking member adapted to lock with a locking member arranged on the barrel. The barrel, the plunger, and a hub portion of the needle unit may each comprise a synthetic resin material. The needle unit may comprise a generally cylindrical hub and a hollow needle projecting from the hub. The needle may comprise at least one of metal and stainless steel. The barrel may comprise at least one releasable retaining member which releasably retains the needle unit in an initial position. The barrel may comprise plural releasable retaining members which each releasably retain the needle unit in an initial position. The barrel may comprise at least one deflectable retaining member which releasably retains the needle unit in an initial position. The barrel may comprise plural deflectable retaining members which each releasably retain the needle unit in an initial position.
The device may further comprise a locking arrangement that is structured and arranged to lock a distal end portion of the plunger to the barrel. The device may further comprise a locking arrangement selectively locking a portion of the plunger to the barrel upon the plunger reaching a substantially fully depressed position. The device may further comprise a biasing member, wherein, when the plunger is moved to a full injection position, the needle unit is automatically caused to retract into the plunger via the spring. The device may further comprise a spring arranged within the barrel, wherein, when the plunger is moved to a full injection position, the needle unit is automatically caused to retract into the plunger via the spring. The device may further comprise a system providing an indication to the user that further forward movement of the plunger will cause the needle unit to automatically retract into the plunger. The device may further comprise a system providing an indication to the user that at least one of the plunger has reached a full injection position and the further forward movement of the plunger will cause the needle unit to automatically retract into the plunger.
According to one non-limiting aspect of the invention there is provided a syringe comprising a barrel, a plunger having a portion structured and arranged to move within the barrel, a needle unit, and a safety system that one of automatically causes the needle unit to retract into the plunger when the plunger reaches a substantially fully depressed position and utilizes a frangible or breakable seal arranged within the plunger.
The syringe may further comprise a system providing an indication to the user that the plunger has reached a full injection position and the further forward movement of the plunger will cause the needle unit to automatically retract into the plunger.
According to one non-limiting aspect of the invention there is provided a single-use syringe comprising a barrel, a hollow plunger having a portion structured and arranged to move within the barrel, a needle unit, and a safety system that one of automatically causes the needle unit to retract into the plunger when the plunger reaches a substantially fully depressed position and utilizes a frangible or breakable seal arranged within the plunger.
The syringe may further comprise a system providing an indication to the user that the plunger has reached a full injection position and the further forward movement of the plunger will cause the needle unit to automatically retract into the plunger.
According to one non-limiting aspect of the invention there is provided a method of using the injection device described above, wherein the method comprises moving the plunger away from the needle unit so as to cause a desired amount of medicine to enter into the barrel and moving the plunger towards the needle unit so as to cause medicine to exit the barrel through the needle. The method may further comprise locking the plunger to the barrel to prevent re-use of the syringe.
Other exemplary embodiments and advantages of the present invention may be ascertained by reviewing the present disclosure and the accompanying drawing.
The present invention is further described in the detailed description which follows, in reference to the noted plurality of drawings by way of non-limiting examples of exemplary embodiments of the present invention, in which like reference numerals represent similar parts throughout the several views of the drawings, and wherein:
a shows a rear end view of the device of
Referring now to the drawings and first to
A needle support 30 has a hub portion 31 that is substantially axially retained within a proximal area of the body 10 (see
Substantially arranged within the barrel 10 of the syringe is movably disposed a plunger 20. The plunger 20, like the syringe body 10, includes an end flange 21 which is typically engaged by the thumb of the user while the transverse flange 11 is engaged by the fingers of the user in order to enable the plunger 20 to be forced into the barrel 10 for the purpose of expelling the medicament from the barrel 10 through the needle 32. The plunger 20 additionally includes a generally cylindrical space 22 which is sized to receive therein the needle unit 30 (see
As is apparent from
The operation of the device shown
In embodiments, the engagement between the deflectable retaining members 15 and the hub 31 is removed or disengages prior to the sealing engagement between the seal 25 and the plunger 20. In other embodiments, the engagement between the deflectable retaining members 15 and the hub 31 is removed or disengages just prior to the sealing engagement between the seal 25 and the plunger 20. In embodiments, the engagement between the deflectable retaining members 15 and the hub 31 is not removed or disengaged until after the frangible sealing engagement between the seal 25 and the plunger 20 is broken. In embodiments, the engagement between the deflectable retaining members 15 and the hub 31 is not removed or disengaged until just after the frangible sealing engagement between the seal 25 and the plunger 20 is broken. In embodiments, the force required to unlock or remove the engagement between the deflectable retaining members 15 and the hub 31 is less than that required to break the sealing engagement between the seal 25 and the plunger 20. In embodiments, the force required to unlock or remove the engagement between the deflectable retaining members 15 and the hub 31 is greater than that required to break the sealing engagement between the seal 25 and the plunger 20. In embodiments, the force required to unlock or remove the engagement between the deflectable retaining members 15 and the hub 31 is substantially equal to that required to break the sealing engagement between the seal 25 and the plunger 20. In embodiments, a noise is produced (providing an auditory signal to the user) when the engagement between the deflectable retaining members 15 and the hub 31 is removed. In embodiments, a noise is produced (providing an auditory signal to the user) when the sealing engagement between the seal 25 and the plunger 20 is broken. In embodiments, a visual indication is produced (providing a visual signal to the user) when the engagement between the deflectable retaining members 15 and the hub 31 is removed. In embodiments, a visual indication is produced (providing a visual signal to the user) when the sealing engagement between the seal 25 and the plunger 20 is broken. Such visual indicators can be facilitated by making the plunger 20 and body 10 substantially transparent and/or translucent.
The devices described herein can also utilize one or more features disclosed in prior art documents expressly incorporated by reference in pending U.S. patent application Ser. No. 11/616,196 (Publication No. 2008/0154212). This application and the documents expressly incorporated therein is hereby expressly incorporated by reference in the instant application. Furthermore, one or more of the various parts of the device can preferably be made as one-piece structures by e.g., injection molding, when doing so reduces costs of manufacture. Non-limiting materials for most of the parts include synthetic resins such as those approved for syringes, blood collection devices, or other medical devices. Furthermore, the invention also contemplates that any or all disclosed features of one embodiment may be used on other disclosed embodiments, to the extent such modifications function for their intended purpose.
It is noted that the foregoing examples have been provided merely for the purpose of explanation and are in no way to be construed as limiting of the present invention. While the present invention has been described with reference to an exemplary embodiment, it is understood that the words which have been used herein are words of description and illustration, rather than words of limitation. Changes may be made, within the purview of the appended claims, as presently stated and as amended, without departing from the scope and spirit of the present invention in its aspects. Although the present invention has been described herein with reference to particular means, materials and embodiments, the present invention is not intended to be limited to the particulars disclosed herein; rather, the present invention extends to all functionally equivalent structures, methods and uses, such as are within the scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4650468 | Jennings, Jr. | Mar 1987 | A |
4929238 | Baum | May 1990 | A |
4946441 | Laderoute | Aug 1990 | A |
5002533 | Jullien | Mar 1991 | A |
5019044 | Tsao | May 1991 | A |
5049133 | Villen Pascual | Sep 1991 | A |
5053010 | McGary et al. | Oct 1991 | A |
5098402 | Davis | Mar 1992 | A |
5125898 | Kaufhold, Jr. et al. | Jun 1992 | A |
5127906 | Landry et al. | Jul 1992 | A |
5167635 | Haber et al. | Dec 1992 | A |
5188599 | Botich et al. | Feb 1993 | A |
5188600 | Jullien | Feb 1993 | A |
5190526 | Murray et al. | Mar 1993 | A |
5211628 | Marshall | May 1993 | A |
5242401 | Colsky | Sep 1993 | A |
5267977 | Feeney, Jr. | Dec 1993 | A |
5308329 | Mazur et al. | May 1994 | A |
5328475 | Chen | Jul 1994 | A |
5336198 | Silver et al. | Aug 1994 | A |
5344403 | Lee | Sep 1994 | A |
5376080 | Petrussa | Dec 1994 | A |
5401249 | Shields | Mar 1995 | A |
5403286 | Lockwood, Jr. | Apr 1995 | A |
5407436 | Toft et al. | Apr 1995 | A |
5498241 | Fabozzi | Mar 1996 | A |
5531694 | Clemens et al. | Jul 1996 | A |
5569203 | Chen | Oct 1996 | A |
5591131 | Chen | Jan 1997 | A |
5591138 | Vaillancourt | Jan 1997 | A |
5814017 | Kashmer et al. | Sep 1998 | A |
5858000 | Novacek et al. | Jan 1999 | A |
6010486 | Carter et al. | Jan 2000 | A |
6074370 | Pressly, Sr. et al. | Jun 2000 | A |
6074373 | Sudo et al. | Jun 2000 | A |
6083199 | Thorley et al. | Jul 2000 | A |
6179812 | Botich et al. | Jan 2001 | B1 |
6183440 | Bell | Feb 2001 | B1 |
6210371 | Shaw | Apr 2001 | B1 |
D452000 | Crawford et al. | Dec 2001 | S |
6368303 | Caizza | Apr 2002 | B1 |
6375640 | Teraoka | Apr 2002 | B1 |
6461328 | Wang et al. | Oct 2002 | B2 |
6517516 | Caizza | Feb 2003 | B1 |
6632198 | Caizza | Oct 2003 | B2 |
6648849 | Tenhuisen et al. | Nov 2003 | B2 |
6840291 | Caizza et al. | Jan 2005 | B2 |
7090656 | Botich et al. | Aug 2006 | B1 |
7144387 | Millerd | Dec 2006 | B2 |
7150725 | Wilkinson | Dec 2006 | B2 |
7322963 | Goh | Jan 2008 | B2 |
7413560 | Chong et al. | Aug 2008 | B2 |
7428773 | Newby et al. | Sep 2008 | B2 |
7500967 | Thorley et al. | Mar 2009 | B2 |
7604613 | Crawford et al. | Oct 2009 | B2 |
7803132 | Janek et al. | Sep 2010 | B2 |
7846135 | Runfola | Dec 2010 | B2 |
7935087 | Judd et al. | May 2011 | B2 |
8002745 | Kaal et al. | Aug 2011 | B2 |
8012132 | Lum et al. | Sep 2011 | B2 |
8021333 | Kaal et al. | Sep 2011 | B2 |
8052654 | Kaal et al. | Nov 2011 | B2 |
8114050 | Kaal et al. | Feb 2012 | B2 |
8147450 | Yang | Apr 2012 | B2 |
20030004491 | Tenhuisen et al. | Jan 2003 | A1 |
20040254529 | Fitzgeald | Dec 2004 | A1 |
20050159705 | Crawford et al. | Jul 2005 | A1 |
20060084913 | Lo | Apr 2006 | A1 |
20080154212 | Schraga | Jun 2008 | A1 |
20100262119 | Schraga | Oct 2010 | A1 |
20110092902 | Kiehne | Apr 2011 | A1 |
20110125130 | Schraga | May 2011 | A1 |
20110213304 | Schraga | Sep 2011 | A1 |
Number | Date | Country |
---|---|---|
2 251 054 | Nov 2010 | EP |
2 266 667 | Nov 1993 | GB |
WO9103269 | Mar 1991 | WO |
Number | Date | Country | |
---|---|---|---|
20100262119 A1 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
61167741 | Apr 2009 | US |